F
unctional tricuspid regurgitation (TR) is one of the most common valvular disorders seen among heart failure patients (1) , and its presence is associated with a worse clinical prognosis (2, 3) . In the adult population, primary tricuspid valve disease is rare, and TR usually results from chronic underlying mitral valve conditions. The therapeutic approach to "functional TR" has historically been conservative and focused on treating the underlying mitral valve pathology first (4) . Recent data suggest that medically treated TR continues to worsen over time and carries a worse prognosis among patients undergoing mitral valve surgery (5) . In the last several years, a growing academic interest in the early diagnosis and therapy of the so-called "forgotten valve" is gaining momentum. Science author instructions page. 
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